Please login to the form below

Not currently logged in
Email:
Password:

EMA publishes drug information format

The European Medicines Agency has published the format in which pharmaceutical companies are to submit information on all medicines registered in the European Union

The European Medicines Agency (EMA) has published the format in which pharmaceutical companies are to submit information on all medicines registered in the European Union (EU).

The latest requirement is part of the agency's pharmacovigilance plans to strengthen systems to monitor the safety of medicines in the EU, and increases transparency and access to information.

Companies will need to submit relevant information outlined in the guidance by July 2, 2012.

The EMA has said the data will enable the creation of a list of all medicines authorised and registered in the EU, both by the EMA and national regulatory bodies.

The plans will also improve the identification of medicines and better co-ordinate their regulation and monitoring, according to the EMA.

Beginning in autumn, companies can organise online and face-to-face sessions with the agency to discuss the requirements. The EMA has also designed a data-entry tool to help small and medium-sized businesses.

The EMA has further information on the new format for information on medicines.

4th July 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....